Is there any way to get a better outcome for the public here, or is “do good stuff then sell out” the way it’s always going to be?
In the end, incentives matter.
Outside software technology: there is a series of papers from Grossman (going back to the 80s!) that analyzes basic versus applied research in a macroeconomic framework. Basic research _can_ be a public good, applied research can be crowded out. Combined with microeconomic research that monopolies can be dynamically efficient (investing in applied and basic R&D, like Bell Labs) and you get several examples and theories that contradict your statement that "there is no private market entity with an incentive to provide research to the public."
Another real world example in hardware that contradicts this claim is the evolution of building control systems. Before the advent of IOT, so, circa 1980s - 2010s, you saw increasing sharing and harmonization of competing electronics standards because it turned out to be more efficient to be modular, not have to re-hire subcontractors at exorbitant rates to maintain or replace components that go haywire, etc.
Economic analysis? Another intelligence product that requires essentially no staff, no actual R&D, no equipment besides computers? Brother, you have to be kidding me.
The hardware thing is just companies evolving to a shared standard.
Do you have even a little bit of a clue how hard it is to do good pharmacological research? Toxicological? Biological? Chemical? Physical? You have mentioned intelligence products with 0 investment cost and 0 risk of failure.
This is perhaps one of the most fart-sniffing tech-centric perspectives I have ever been exposed to. Go read some actual research by actual scientists and come back when you can tell me why, for instance, Eli Lilley would ever make their data or internal R&D public.
Jonas Salk did it. He is an extremely rare exception, and his incentive was public health. Notice that his incentive was markedly not financial.
Market entities with a financial incentive, whose entire business model and success is predicated on their unique R&D results, have 0 incentive to release research to the public.
(1) FOSS is not only the next hyped front-end framework or modern data stack funnel. I encourage you to do more research for what European universities and organizations are doing. Not everyone follows the American or Chinese extractive approaches to software.
Further, while many corporations do indeed farm social capital and perform other appreciably maladative and cynic-inducing behaviors, the universe and the space of organizations is large. There are a great many examples of governments adopting public research and development released by private entities -- in FOSS and in other contexts.
Additionally, the fact that FOSS-product-focused companies tend to launch _after_ FOSS becomes successful to support the FOSS offering with associated services is quite a bit different from what is perhaps a FAANG-induced cynicism. To reiterate - the universe and the space of organizations is large.
(2) You interpreted that I did pointed to economic analysis as public vs. private R&D. This is a misinterpretation on your part and I encourage a re-read. I pointed to findings and studies to help you understand where the organizational and market frameworks for analysis stand.
(3) I am a researcher and regularly publish my findings, under the banner of the university I support, under non-profits I support, and under the company I run. I appreciate your experience has made you cynical. Lets break down this section.
> This is perhaps one of the most fart-sniffing tech-centric perspectives I have ever been exposed to.
This was not received as a good-faith statement, and further discussion on it will only engender argument. I suggest we move beyond trivial digs.
> Eli Lilley would ever make their data or internal R&D public.
Not to shill for them, but your point on Eli Lilly is incorrect. Eli Lilly has worked towards more transparent release of information -- they voluntarily launched an online clinical trial registry starting in 2002 (for Phase II–IV trials initiated on/after October 15, 2002) and extended full trial registration (including Phase I) from October 1, 2010.[0] Since 2014, Lilly has published clinical study results (Phase 2/3) regardless of outcome, adhering to PhRMA/EFPIA transparency principles. Patient-level data on marketed-approved indications is available to qualified researchers via a controlled-access third-party portal.[1] Beginning in 2021, Lilly has also produced plain‑language summaries of Phase 2–4 results in English, and more recently extended plain‑language summaries to Phase 1 trials in the EU in compliance with new regulations.[1]
Especially the third point is relevant -- good government regulation leads to better sharing and transparency. Smart companies take regulation as an innovation opportunity.
> Jonas Salk did it. He is an extremely rare exception, and his incentive was public health. Notice that his incentive was markedly not financial.
Aye, and I wish that all medical and life-enhancing research could be accomplished as relatively cheaply or as magnanimously as Jonas Salk.
> Market entities with a financial incentive, whose entire business model and success is predicated on their unique R&D results, have 0 incentive to release research to the public.
Please refer to (2) for studies and theory for why this is untrue.
The number of market entities who only are built on unique R&D tend to fail due to poor delivery of product, so their incentive to release their R&D to the world is more or less moot. I do acknowledge existence of market entities who are built solely on operationalizing R&D -- I challenge the implicit claim that all market entities fall into this category.
[0] https://www.lilly.com/au/policies-reports/transparency-discl...
[1] https://sustainability.lilly.com/governance/business-ethics
They were also forced in the 1950s to license all their innovations freely, as compensation for holding a monopoly. Which only strengthens the parent’s point that private institutions have little incentive to work for public benefit.
If we're talking about applied technology in the public goods space, then it can be a toss up. Sustainability research, for example, can be quite blurry as to whether the market is pricing it in or not as applied or basic research -- really depends on how a government handles externalities and regulatory capture!
I'll 100% agree to government entities as well as some well-chartered public entities being absolutely awesome at setting up incentive structures for desired outcomes. There is actually a whole field of research dedicated to the topic of incentive structuring called mechanism design -- think of it as the converse to Game Theory and strategic behavioral analysis -- that policy design and analysis learn from.
I'll also note that governments aren't structured to efficiently provide benefits or just-in-time delivery in most situations. Though the discussion has made me more curious about how operationally efficient the DOD is for civilian goods distribution, given it supports a massive population.
This kind of discussion is a bit off topic here, but I think it is important to remind people that the idea that private always is better than public is ideological dogma, not science. But your latest comment makes me believe you agree with that.
A moderate path, like what we see in the Scandinavian countries, looks to be a better model.
How that is in practice, I'm not sure, and I'm sure with some sleuthing it would be possible to find out at least some of it. But on the whole, I'm honestly not sure beyond that.
There was also the Waymo ad and the Rods from the Gods video where he couldn't bother to use a guide wire to aim.
There second one takes a mathematical model for the path integral for light and portrays it like that's actually what is happening, with plenty of phrases like light "chooses" the path of least action that imply something more going on. Also, the experiment at the end with the laser pointer is awful. The light we are seeing is scattering from the laser pointer's aperture, not some evidence that light is taking alternate paths.
Many people said this, but he set up an experiment to test it and the light does turn on instantly as claimed: https://www.youtube.com/watch?v=oI_X2cMHNe0
> There second one takes a mathematical model for the path integral for light and portrays it like that's actually what is happening
I know nothing about this. Is there a more accurate mathematical model available than the one he uses? Otherwise, I think it seems sensible to portray our best mathematical model as "what's really going on". And I didn't get the sense that light was "choosing" anything when watching the video, I got the sense that the amplitudes of all possible paths were cancelling out except for the shortest path (or something along those lines)
The words people like to use for the path integral is a sum over histories---that corresponds tightly with the ingredients in the path integral. So in this formulation it's what's "actually happening". But in other mathematical formulations other words are more appealing and what someone claims is "actually happening" sounds different.
Her latest video, showing her out of bed and going for short walks, is here: https://youtu.be/vqeIeIcDHD0?si=WoxpqZOuRTWD2XYd
See: Brian Keating licking Eric Weinstein's jock strap in public and then offering mild criticism on Piers Morgan.
If transparent enough (and not from an abhorrent source), I'd be ok with his product. He's even allowed to make the occasional mistake as long as he properly owns up to it.
Theres been a lot of valuable learning from him and it would be a pity to dismiss it all over a single fumble.
You can, actually, with a simple rule of thumb: if it's being advertised on YouTube, it's statistically low quality or a scam. The sheer number of brands that sponsor videos just to be exposed later for doing something shady is just too high.
I thought it goes without saying that I don't mean ads shown directly by YouTube, if you don't already block those in 2025 I don't know what to say.